Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma

Clinical Cancer Research

Volumn 11, Issue 7, 2005, Pages 2597-2605

  Hashimoto, Yosuke ^a   Ito, Tetsuo ^a   Inoue, Harutaka ^a   Okumura, Tomoyuki ^a   Tanaka, Eiji ^a   Tsunoda, Shigeru ^a   Higashiyama, Motoshige ^a   Watanabe, Go ^a   Imamura, Masayuki ^b   Shimada, Yutaka ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Dept of Respiratory Medicine Saiseikai Noe Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIN; MESSENGER RNA; PARAFFIN; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 20244381388     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1378     Document Type: Article

References (36)

1. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three field lymph node dissection of esophageal cancer. Oncology 1991;48:411-20.
2. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
3. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993;71:1368-83.
4. Partin AW, Schoeniger JS, Mohler JL, Coffey DS. Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci U S A 1989;86:1254-8.
5. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-9.
6. Otto JJ. Actin-bundling proteins. Curr Opin Cell Biol 1994;6:105-9.
7. Tilney LG, Connelly PS, Vranich KA, Shaw MK, Guild GM. Why are two different cross-linkers necessary for actin bundle formation in vivo and what does each cross-link contribute? J Cell Biol 1998;143:121-33.
8. Matsudaira P. Actin crosslinking proteins at the leading edge. Semin Cell Biol 1994;5:165-74.
9. Bryan J, Kane RE. Separation and interaction of the major components of sea urchin actin gel. J Mol Biol 1978 Oct 25;125:207-24.
10. Otto JJ, Kane RE, Bryan J. Formation of filopodia in coelomocytes: localization of fascin, a 58,000 dalton actin cross-linking protein. Cell 1979 Jun;17:285-93.
11. Bryan J. Isolation of fascin, an actin-bundling protein, and SU45, an actin-severing/capping protein from sea urchin eggs. Methods Enzymol 1986;134:13-23.
12. Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC. Fascins, and their roles in cell structure and function. Bioessays 2002;24:350-61.
13. Duh FM, Latif F, Weng Y, et al. cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol 1994;13:821-7.
14. Yamashiro-Matsumura S, Matsumura F. Intracellular localization of the 55-kD actin-bundling protein in cultured cells: spatial relationships with actin, α-actinin, tropomyosin, and fimbrin. J Cell Biol 1986 Aug;103:631-40.
15. Adams JC. Cell-matrix contact structures. Cell Mol Life Sci 2001 Mar;58:371-92.
16. Yamashiro S, Yamakita Y, Ono S, Matsumura F. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998;9:993-1006.
17. Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000;18:83-8.
18. Grothey A, Hashizume R, Sahin AA, McCrea PD. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000;83:870-3.
19. Grothey A, Hashizume R, Ji H, et al. C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 2000;19:4864-75.
20. Guvakova MA, Boettiger D, Adams JC. Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-1 receptor. Int J Biochem Cell Biol 2002;34:685-98.
21. Maitra A, Iacobuzio-Donahue C, Rahman A, et al. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 2002;118:52-9.
22. Jawhari AU, Buda A, Jenkins M, et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003;162:69-80.
23. Pelosi G, Pastorino U, Pasini F, et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003;88:537-47.
24. Goncharuk VN, Ross JS, Carlson JA. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002;29:430-8.
25. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-70.
26. Sobin LH, Wittekind Ch, editors. TNM classification of malignant tumours. 6th ed. New York: John Wiley & Sons, Inc.; 2002.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
28. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993;15:532-4, 536-7.
29. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992;69:277-84.
30. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002;16:948-58.
31. Sui G, Soohoo C, Affar EB, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002;99:5515-20.
32. Brummelkamp TR, Bernards R, Agami R. A system for stable Expression of short interfering RNAs in mammalian cells. Science 2002;296:550-3.
33. Wong V, Ching D, McCrea PD, Firestone GL. Glucocorticoid down-regulation of fascin protein expression is required for the steroid-induced formation of tight junctions and cell-cell interactions in rat mammary epithelial tumor cells. J Biol Chem 1999;274:5443-53.
34. Tao YS, Edwards RA, Tubb B, Wang S, Bryan J, McCrea PD. β-Catenin associates with the actin-bundling protein fascin in a non-cadherin complex. J Cell Biol 1996;134:1271-81.
35. Hardwick RH, Barham CP, Ozua P, et al. Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. Eur J Surg Oncol 1997 Feb;23:30-5.
36. Powell SM, Papadopoulos N, Kinzler KW, Smolinski KN, Meltzer SJ. APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology 1994 Dec;107:1759-63.